{"name":"Guangzhou Lupeng Pharmaceutical Company LTD.","slug":"guangzhou-lupeng-pharmaceutical-company-ltd","ticker":"","exchange":"","domain":"guangzhoulupengcompany.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNYk5fUTdiZXJyZXNiS3ZQc1ZYRldqQ1BKQ2tEcVdqRlZ1U0o2dzNLSEwyU2o3czBDVnpKWC1aYnFJMVNUZ0hDZFRpS2trZGpzUGRJcXltYXoxYWdaLXhzems0VG1ObS1sRzdmUmJ1OFpnSHVwcXpCQXlvdVcxcjJOTWlVTHllcFZRWWItWGJneXI3cGdVb3lXS0RRRktkS0xYMGNqcTY2eXRWTHBTM0NrTGJvRjN6a2ctZWlKTzQyZFZMNWlTWDU1SzZINjh4bVdOVkUxMHhhSjAzX2QxZWMxUDM3MUxSbXVmdkJ2aFhZWGRKbU5IR19kVTN2WVJOSTZkOHpRWWdoVnFFTnNhaGc?oc=5","date":"2026-04-07","type":"trial","source":"Barchart.com","summary":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Trea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPRmg1SzBUUE4zV0FuY2JXa20wZ0hYNHdNWG1EUG5NMGNFNDh4eE9sbDFSXzNSeGJxdEN1X1o3UG5tWEI3bUc2NzRSa3JQM0xENUhiVEczQW9FTEhnZVM3bUtnZW9oT1lvQ2lleFloMkJmMnpvY0JWYW01Tk8xRlhsWi1uTTA1cjNuaFZHcGlad2d6UE9PMmlXUG1n?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Non-Hodgkin Lymphoma Treatment Pipeline Accelerates as 180+ - openPR.com","headline":"Non-Hodgkin Lymphoma Treatment Pipeline Accelerates as 180+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNMjVkdDZGZ1hUMURQVWczOWVkSkNGeUd5WVkyUXRKeGJCZWFPYkRsM1Z0bFh3MC1CRTB5b2ExNDh6UV9OTllObHZhN0JYbGZFN3Jpc0E5RFBkMmZNUzZad0lOaHdqdklLQUtVbVF1VmRZdzVBOWFuZzdFYVNpS2ppVk1FanFYU0VEZXhRaHhXM0g1MDctb0xWTTB4VXd1dFl1U0NBS3BERTRGZm1fSTlMVEJfNkN6Q1FqVzYwblFfOXE4VW9kdmhhdlc5QjJCam5BX3MwMkoyakNkOFYyelkxV0VR?oc=5","date":"2025-06-17","type":"pipeline","source":"prnewswire.com","summary":"Chronic Hepatitis B Market--The US to Have the Lion's Share Among the 7MM, Predicts DelveInsight - prnewswire.com","headline":"Chronic Hepatitis B Market--The US to Have the Lion's Share Among the 7MM, Predicts DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOX2xMdVlLZXJlQjY4bWVCQnBoWGdoa0JPNE1mVG5KbjNuYTZabnJoVG9yWnRaU1RRM2tMZGFHMEF1Z0NuMXpqa3hfNUtXelNaWXNtOW9WSWt1cU02RXlVemwtR2JVVEVjcTUtNVR6aXlsM3ByU0hjUktBeUtiS1hGV0FOY2VrY3Z2VXlHVHZLOUxoMjlSYWU4TjRNX2JrOTBBSjFfeUE5Z0wxcEV3SDZZZ1J2N0JwRzZubTJ0SklzbFlWVThhbC16ZFVUT2J6UTRySmxmSnRwVQ?oc=5","date":"2025-03-05","type":"pipeline","source":"prnewswire.com","summary":"Global Interferons Market is Predicted to Reach ~USD 14 Billion by 2032 | DelveInsight - prnewswire.com","headline":"Global Interferons Market is Predicted to Reach ~USD 14 Billion by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNYVZGb1d4SlV6bHhTQ0RSVURidk9lekxZR0JyZlM1OEFCcmNBcnpaNGZCZzdybERwZFNjb2VSSjJmWXJpdUMwbWMxZW93ZXY0SV8wUDRBSVRaaFRxeFpPNXFCZ3JqQUpwbEtWdFNEY2lPYURISVF2QmV4aG8zdmw0dlpxV0RFT3VnV29fRmdkdDd3WkVrM1VJaU5rb0J3aHdGbkhGeE0yRFM4clBOQWxGT0JaTFcxS3VlVHZzNHU1YjlhQlEtcG1OUjlzdEp1QjU5RlNBeXNlcHZJLVl6SVBONkdkTQ?oc=5","date":"2024-11-13","type":"pipeline","source":"prnewswire.com","summary":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight - prnewswire.com","headline":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPTFNCUXNvcmpxdDBPQzhIUXMwWU5zNF9RMEMxRlhrYUZPWHVvX3ZoblgzNEM4cmxuNlJOa2l6dzA2WTBZNmZjWm1JczR3TFN2ZGlCMjVYMl91cEt0dVp1X21vU01kemhnSkREWG1naE9pb244RkNxOWRDZW9fQV9HbzBRczYwRV9lQzA2UWNQVmtPVWxUZjhrZkFaRUZUeGFfcUlaNmtpbkltY052enhVTlJrRVVYdWk3TjhHcGRCQ19IaVZWZ1lnZVYwUE1uUmRJTXBQNlRkNEFMWTk1bTdr?oc=5","date":"2024-09-19","type":"trial","source":"prnewswire.com","summary":"Mantle Cell Lymphoma Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight - prnewswire.com","headline":"Mantle Cell Lymphoma Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-05-31","type":"trial","source":"GlobeNewswire","summary":"B-Cell Lymphoma Clinical Trial Pipeline Insights: - GlobeNewswire","headline":"B-Cell Lymphoma Clinical Trial Pipeline Insights:","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}